Skip to main content
logo
Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
33.56
+0.09 (0.27%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Agios Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
98.3454.0336.526.8214.24-
Revenue Growth
140.58%48.03%36.07%88.36%--
Gross Profit
-266.29-291.85-268.95-271.58-267.37-256.97
Operating Income
-459.02-472.13-425.74-391.49-389.05-378.42
Net Income
-411.29-412.78673.73-352.09-231.81,605
Earnings Per Share
-7.01-7.1211.64-6.33-4.2326.55
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
964.831,1641,532806.361,0971,286
Total Debt
31.1740.2156.997285.6697.09
Net Cash (Debt)
933.661,1241,475734.371,0111,189
Net Cash Growth
-27.66%-23.78%100.86%-27.39%-14.96%110.37%
Net Cash Per Share
15.9119.3925.4813.2018.4619.67

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-360.6-372.98-389.84-296.06-309.48-407.32
Capital Expenditures
-4.66-4.32-1.69-1-4.88-5.74
Free Cash Flow
-365.25-377.29-391.53-297.06-314.36-413.06
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-270.79%-----
Operating Margin
-466.78%-873.87%-1166.47%-1459.52%-2732.07%-
Pretax Margin
-419.27%-765.89%1967.15%-1312.63%-1627.82%-
Profit Margin
-418.24%-764.01%1845.92%-1312.63%-1627.82%-
FCF Margin
-371.42%-698.33%-1072.73%-1107.49%-2207.58%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.78--1.11
Forward PE
-7.847.84---
PS Ratio
20.3729.3851.3546.40108.35-